MannKind (MNKD) has a market capitalization of approximately
.88 on the NASDAQ. Market cap moves with the live share price.MannKind runs a net profit margin of -6.6%, a gross margin of 76.0%, and an operating margin of 3.7%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
MannKind reported revenue of
MannKind does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
MannKind carries a debt-to-equity ratio of -7.38x and a current ratio of 1.87x, with a market beta of 1.09. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For MannKind (MNKD) the key facts are: market cap
49M, 52-week range 2.23-6.51. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.Get MannKind's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.